Assignee
ADICET THERAPEUTICS INC
US·4 granted patents·4 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
8 records- 0170US12364714B2Methods for selective expansion of gamma delta t-cell populations and compositions thereofADICET THERAPEUTICS INC·Filed 2022·Granted Jul 22, 2025·0 cites·31 claims
- 0267US12371663B2Engineered γδ T-cellsADICET THERAPEUTICS INC·Filed 2021·Granted Jul 29, 2025·0 cites·13 claims
- 0363US2025345429A1Compositions and methods comprising chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0460US2025108069A1Chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0559US12252547B2Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of sameADICET THERAPEUTICS INC·Filed 2021·Granted Mar 18, 2025·0 cites·16 claims
- 0650US2025085287A1Methods for detection of membrane bound glypican-3ADICET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0749US2025025504A1Treatment of b cell malignanciesADICET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0839US12221480B2Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereofADICET THERAPEUTICS INC·Filed 2018·Granted Feb 11, 2025·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when ADICET THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →